QR код

CILO-CLOP Trial: Cilostazol Versus Clopidogrel in Acute Moderate and Moderate-to-Severe Ischemic Stroke: A Randomized Controlled Multicenter Trial

Abstract Introduction All large studies evaluating the role of cilostazol versus other antiplatelet agents in stroke prevention have been conducted in Asia and included patients with minor stroke or transient ischemic attack (TIA). Ours is the first-ever trial to evaluate the safety and efficacy of...

Повний опис

Збережено в:
Автори: Mohamed G. Zeinhom, Mohamed Ismaiel, Mohamed Fouad Elsayed Khalil, Mohamed Ahmed Almoataz, Tarek Youssif Omar, Ahmed Mohamed Ali Daabis, Hossam Mohamed Refat, Ahmed Ahmed Mohamed Kamal Ebied, Noha Abdelwahed, Ahmed Zaki Omar Akl, Emad Labib Abdelhamid Mahmoud, Salah Ibrahim Ahmed, Sherihan Rezk Ahmed
Формат: Artigo
Мова:Inglês
Опубліковано: Adis, Springer Healthcare 2025-04-01
Серія:Neurology and Therapy
Предмети:
Cilostazol
Egypt
Clopidogrel
Moderate ischemic stroke
Moderate-to-severe stroke
Онлайн доступ:https://doi.org/10.1007/s40120-025-00739-5
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси